
With years of specialized experience, our team understands the complexities of dermatological research, ensuring optimized study designs and outcomes tailored specifically for your product¡¯s needs.
Our AAALAC accreditation and adherence to GLP guidelines ensure rigorous quality control across all studies, resulting in reproducible and reliable data that meets the highest industry standards.
We accommodate varying project scales with flexible minimum order quantities, enabling a tailored approach that suits both small startups and large pharmaceutical firms in their dermatology studies.
KCI Biotech offers an integrated range of preclinical drug development services, providing one-stop solutions for dermatology including toxicology, pathology, and pharmacology assessments.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china